View in EDS HTML Full Text PDF Full Text

The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines.

Saved in:
Bibliographic Details
Title: The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines.
Authors: Naeimi, Arvin1 (AUTHOR), Saedi, Hamid Saeidi2 (AUTHOR), Bakhtiyari, Amir Mohsen1 (AUTHOR), Shabani, Kimia1 (AUTHOR), Babajani, Zahra1 (AUTHOR), Zahmatkesh, Mona Haddad3 (AUTHOR) haddad@gums.ac.ir
Source: Research in Pharmaceutical Sciences. Jan/Feb2026, Vol. 21 Issue 1, p96-109. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17355362
DOI:10.4103/RPS.RPS_191_24